Repligen Corporation Common Stock vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Repligen Corporation Common Stock trades at $178.2 (market cap $11.31B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $42 (market cap $3.80B). The key difference: Repligen Corporation Common Stock is far larger — about 3× Vanguard Global ex-US Real Estate Index Fd ETF's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Vanguard Global ex-US Real Estate Index Fd ETF for 96 Days on average.
| RGEN | VNQI | |
|---|---|---|
Market Cap | $11.31B | $3.80B |
Volume | 1,216,919 | 216,754 |
Sector | Health | — |
52-Week High | $194.57 | $50.76 |
52-Week Low | $102.87 | $41.81 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $11.20B | — |
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $42.04, showing minimal daily movement with a 0.14% gain. Technical indicators signal a bearish trend with moving averages pointing downward, though oscillators remain neutral. The ETF focuses on international real estate across 30+ countries, offering a higher dividend yield than domestic counterparts but has faced recent price pressure, trading below its 50-day moving average of $45.50 as of September 2026.
The outlook remains cautious due to global real estate market volatility and underperformance relative to U.S. alternatives. Key opportunities include diversification benefits and attractive dividend yield, while risks involve currency fluctuations, international economic instability, and competitive pressure from lower-cost ETFs. Short interest declined significantly in September 2026, suggesting reduced bearish sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →